207_Combined course Presentations
Phase III Stage III + IVA EC
• Primary endpoint
– Recurrence-free survival
• Secondary endpoint – Overall survival • Target accrual = 450 – Study start
March 2015 – Study end date March 2023
Made with FlippingBook
Phase III Stage III + IVA EC
• Primary endpoint
– Recurrence-free survival
• Secondary endpoint – Overall survival • Target accrual = 450 – Study start
March 2015 – Study end date March 2023
Made with FlippingBook